2012ENDO 高甘油三酯血症的评估和治疗临床实践指南

2012-10-02 MedSci MedSci原创

由工作组组长加州大学戴维斯分校Lars Berglund医师领衔制定的新建议已发表在2012年9月的《临床内分泌和代谢杂志》。在这篇综述中,专家组指出,虽然有可靠证据支持LDL胆固醇水平和心血管疾病之间存在相关性,但甘油三酯水平和心血管疾病之间的相关性则更为不确定。然而,他们建议筛查甘油三酯水平高的成人作为空腹血脂组工作的一部分。 成人应每5年接受一次高甘油三脂水平筛查,因为他们可能具有与高甘

由工作组组长加州大学戴维斯分校Lars Berglund医师领衔制定的新建议已发表在2012年9月的《临床内分泌和代谢杂志》。在这篇综述中,专家组指出,虽然有可靠证据支持LDL胆固醇水平和心血管疾病之间存在相关性,但甘油三酯水平和心血管疾病之间的相关性则更为不确定。然而,他们建议筛查甘油三酯水平高的成人作为空腹血脂组工作的一部分。

成人应每5年接受一次高甘油三脂水平筛查,因为他们可能具有与高甘油三脂相关的心血管疾病和胰腺炎风险。甘油三酯水平高的个体应进一步接受其他心血管危险因素评估,例如肥胖症、高血压、葡萄糖代谢异常和肝功能障碍。

2012ENDO 高甘油三酯血症的评估和治疗临床实践指南.pdf

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1654705, encodeId=7f221654e05ff, content=<a href='/topic/show?id=edc610251468' target=_blank style='color:#2F92EE;'>#高甘油三酯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102514, encryptionId=edc610251468, topicName=高甘油三酯)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5a424532179, createdName=flyingeagle85, createdTime=Sat Nov 10 14:01:00 CST 2012, time=2012-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2030968, encodeId=fbf32030968b3, content=<a href='/topic/show?id=5df2460e269' target=_blank style='color:#2F92EE;'>#实践指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46072, encryptionId=5df2460e269, topicName=实践指南)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=796422, createdName=lvliquan, createdTime=Sun Mar 24 04:01:00 CST 2013, time=2013-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5153, encodeId=b282515310, content=有现实意义, beContent=null, objectType=article, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed5e73319, createdName=luglei, createdTime=Tue Dec 04 01:28:00 CST 2012, time=2012-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5154, encodeId=eeb35154a3, content=有现实意义, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed5e73319, createdName=luglei, createdTime=Tue Dec 04 01:28:00 CST 2012, time=2012-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1323587, encodeId=84c2132358ed9, content=<a href='/topic/show?id=42b922e7350' target=_blank style='color:#2F92EE;'>#临床实践#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22773, encryptionId=42b922e7350, topicName=临床实践)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=35fc2500023, createdName=yanjie6253_56072842, createdTime=Thu Oct 04 14:01:00 CST 2012, time=2012-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486757, encodeId=1d441486e57ce, content=<a href='/topic/show?id=8ca1102515ec' target=_blank style='color:#2F92EE;'>#高甘油三酯血症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102515, encryptionId=8ca1102515ec, topicName=高甘油三酯血症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91bf8208819, createdName=bioon4, createdTime=Thu Oct 04 14:01:00 CST 2012, time=2012-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1571918, encodeId=212915e1918bf, content=<a href='/topic/show?id=413922e74cd' target=_blank style='color:#2F92EE;'>#临床实践指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22774, encryptionId=413922e74cd, topicName=临床实践指南)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=276d15780972, createdName=lily1621, createdTime=Thu Oct 04 14:01:00 CST 2012, time=2012-10-04, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1654705, encodeId=7f221654e05ff, content=<a href='/topic/show?id=edc610251468' target=_blank style='color:#2F92EE;'>#高甘油三酯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102514, encryptionId=edc610251468, topicName=高甘油三酯)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5a424532179, createdName=flyingeagle85, createdTime=Sat Nov 10 14:01:00 CST 2012, time=2012-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2030968, encodeId=fbf32030968b3, content=<a href='/topic/show?id=5df2460e269' target=_blank style='color:#2F92EE;'>#实践指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46072, encryptionId=5df2460e269, topicName=实践指南)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=796422, createdName=lvliquan, createdTime=Sun Mar 24 04:01:00 CST 2013, time=2013-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5153, encodeId=b282515310, content=有现实意义, beContent=null, objectType=article, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed5e73319, createdName=luglei, createdTime=Tue Dec 04 01:28:00 CST 2012, time=2012-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5154, encodeId=eeb35154a3, content=有现实意义, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed5e73319, createdName=luglei, createdTime=Tue Dec 04 01:28:00 CST 2012, time=2012-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1323587, encodeId=84c2132358ed9, content=<a href='/topic/show?id=42b922e7350' target=_blank style='color:#2F92EE;'>#临床实践#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22773, encryptionId=42b922e7350, topicName=临床实践)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=35fc2500023, createdName=yanjie6253_56072842, createdTime=Thu Oct 04 14:01:00 CST 2012, time=2012-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486757, encodeId=1d441486e57ce, content=<a href='/topic/show?id=8ca1102515ec' target=_blank style='color:#2F92EE;'>#高甘油三酯血症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102515, encryptionId=8ca1102515ec, topicName=高甘油三酯血症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91bf8208819, createdName=bioon4, createdTime=Thu Oct 04 14:01:00 CST 2012, time=2012-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1571918, encodeId=212915e1918bf, content=<a href='/topic/show?id=413922e74cd' target=_blank style='color:#2F92EE;'>#临床实践指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22774, encryptionId=413922e74cd, topicName=临床实践指南)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=276d15780972, createdName=lily1621, createdTime=Thu Oct 04 14:01:00 CST 2012, time=2012-10-04, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1654705, encodeId=7f221654e05ff, content=<a href='/topic/show?id=edc610251468' target=_blank style='color:#2F92EE;'>#高甘油三酯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102514, encryptionId=edc610251468, topicName=高甘油三酯)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5a424532179, createdName=flyingeagle85, createdTime=Sat Nov 10 14:01:00 CST 2012, time=2012-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2030968, encodeId=fbf32030968b3, content=<a href='/topic/show?id=5df2460e269' target=_blank style='color:#2F92EE;'>#实践指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46072, encryptionId=5df2460e269, topicName=实践指南)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=796422, createdName=lvliquan, createdTime=Sun Mar 24 04:01:00 CST 2013, time=2013-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5153, encodeId=b282515310, content=有现实意义, beContent=null, objectType=article, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed5e73319, createdName=luglei, createdTime=Tue Dec 04 01:28:00 CST 2012, time=2012-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5154, encodeId=eeb35154a3, content=有现实意义, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed5e73319, createdName=luglei, createdTime=Tue Dec 04 01:28:00 CST 2012, time=2012-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1323587, encodeId=84c2132358ed9, content=<a href='/topic/show?id=42b922e7350' target=_blank style='color:#2F92EE;'>#临床实践#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22773, encryptionId=42b922e7350, topicName=临床实践)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=35fc2500023, createdName=yanjie6253_56072842, createdTime=Thu Oct 04 14:01:00 CST 2012, time=2012-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486757, encodeId=1d441486e57ce, content=<a href='/topic/show?id=8ca1102515ec' target=_blank style='color:#2F92EE;'>#高甘油三酯血症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102515, encryptionId=8ca1102515ec, topicName=高甘油三酯血症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91bf8208819, createdName=bioon4, createdTime=Thu Oct 04 14:01:00 CST 2012, time=2012-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1571918, encodeId=212915e1918bf, content=<a href='/topic/show?id=413922e74cd' target=_blank style='color:#2F92EE;'>#临床实践指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22774, encryptionId=413922e74cd, topicName=临床实践指南)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=276d15780972, createdName=lily1621, createdTime=Thu Oct 04 14:01:00 CST 2012, time=2012-10-04, status=1, ipAttribution=)]
    2012-12-04 luglei

    有现实意义

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1654705, encodeId=7f221654e05ff, content=<a href='/topic/show?id=edc610251468' target=_blank style='color:#2F92EE;'>#高甘油三酯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102514, encryptionId=edc610251468, topicName=高甘油三酯)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5a424532179, createdName=flyingeagle85, createdTime=Sat Nov 10 14:01:00 CST 2012, time=2012-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2030968, encodeId=fbf32030968b3, content=<a href='/topic/show?id=5df2460e269' target=_blank style='color:#2F92EE;'>#实践指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46072, encryptionId=5df2460e269, topicName=实践指南)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=796422, createdName=lvliquan, createdTime=Sun Mar 24 04:01:00 CST 2013, time=2013-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5153, encodeId=b282515310, content=有现实意义, beContent=null, objectType=article, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed5e73319, createdName=luglei, createdTime=Tue Dec 04 01:28:00 CST 2012, time=2012-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5154, encodeId=eeb35154a3, content=有现实意义, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed5e73319, createdName=luglei, createdTime=Tue Dec 04 01:28:00 CST 2012, time=2012-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1323587, encodeId=84c2132358ed9, content=<a href='/topic/show?id=42b922e7350' target=_blank style='color:#2F92EE;'>#临床实践#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22773, encryptionId=42b922e7350, topicName=临床实践)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=35fc2500023, createdName=yanjie6253_56072842, createdTime=Thu Oct 04 14:01:00 CST 2012, time=2012-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486757, encodeId=1d441486e57ce, content=<a href='/topic/show?id=8ca1102515ec' target=_blank style='color:#2F92EE;'>#高甘油三酯血症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102515, encryptionId=8ca1102515ec, topicName=高甘油三酯血症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91bf8208819, createdName=bioon4, createdTime=Thu Oct 04 14:01:00 CST 2012, time=2012-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1571918, encodeId=212915e1918bf, content=<a href='/topic/show?id=413922e74cd' target=_blank style='color:#2F92EE;'>#临床实践指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22774, encryptionId=413922e74cd, topicName=临床实践指南)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=276d15780972, createdName=lily1621, createdTime=Thu Oct 04 14:01:00 CST 2012, time=2012-10-04, status=1, ipAttribution=)]
    2012-12-04 luglei

    有现实意义

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1654705, encodeId=7f221654e05ff, content=<a href='/topic/show?id=edc610251468' target=_blank style='color:#2F92EE;'>#高甘油三酯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102514, encryptionId=edc610251468, topicName=高甘油三酯)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5a424532179, createdName=flyingeagle85, createdTime=Sat Nov 10 14:01:00 CST 2012, time=2012-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2030968, encodeId=fbf32030968b3, content=<a href='/topic/show?id=5df2460e269' target=_blank style='color:#2F92EE;'>#实践指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46072, encryptionId=5df2460e269, topicName=实践指南)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=796422, createdName=lvliquan, createdTime=Sun Mar 24 04:01:00 CST 2013, time=2013-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5153, encodeId=b282515310, content=有现实意义, beContent=null, objectType=article, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed5e73319, createdName=luglei, createdTime=Tue Dec 04 01:28:00 CST 2012, time=2012-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5154, encodeId=eeb35154a3, content=有现实意义, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed5e73319, createdName=luglei, createdTime=Tue Dec 04 01:28:00 CST 2012, time=2012-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1323587, encodeId=84c2132358ed9, content=<a href='/topic/show?id=42b922e7350' target=_blank style='color:#2F92EE;'>#临床实践#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22773, encryptionId=42b922e7350, topicName=临床实践)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=35fc2500023, createdName=yanjie6253_56072842, createdTime=Thu Oct 04 14:01:00 CST 2012, time=2012-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486757, encodeId=1d441486e57ce, content=<a href='/topic/show?id=8ca1102515ec' target=_blank style='color:#2F92EE;'>#高甘油三酯血症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102515, encryptionId=8ca1102515ec, topicName=高甘油三酯血症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91bf8208819, createdName=bioon4, createdTime=Thu Oct 04 14:01:00 CST 2012, time=2012-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1571918, encodeId=212915e1918bf, content=<a href='/topic/show?id=413922e74cd' target=_blank style='color:#2F92EE;'>#临床实践指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22774, encryptionId=413922e74cd, topicName=临床实践指南)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=276d15780972, createdName=lily1621, createdTime=Thu Oct 04 14:01:00 CST 2012, time=2012-10-04, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1654705, encodeId=7f221654e05ff, content=<a href='/topic/show?id=edc610251468' target=_blank style='color:#2F92EE;'>#高甘油三酯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102514, encryptionId=edc610251468, topicName=高甘油三酯)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5a424532179, createdName=flyingeagle85, createdTime=Sat Nov 10 14:01:00 CST 2012, time=2012-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2030968, encodeId=fbf32030968b3, content=<a href='/topic/show?id=5df2460e269' target=_blank style='color:#2F92EE;'>#实践指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46072, encryptionId=5df2460e269, topicName=实践指南)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=796422, createdName=lvliquan, createdTime=Sun Mar 24 04:01:00 CST 2013, time=2013-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5153, encodeId=b282515310, content=有现实意义, beContent=null, objectType=article, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed5e73319, createdName=luglei, createdTime=Tue Dec 04 01:28:00 CST 2012, time=2012-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5154, encodeId=eeb35154a3, content=有现实意义, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed5e73319, createdName=luglei, createdTime=Tue Dec 04 01:28:00 CST 2012, time=2012-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1323587, encodeId=84c2132358ed9, content=<a href='/topic/show?id=42b922e7350' target=_blank style='color:#2F92EE;'>#临床实践#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22773, encryptionId=42b922e7350, topicName=临床实践)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=35fc2500023, createdName=yanjie6253_56072842, createdTime=Thu Oct 04 14:01:00 CST 2012, time=2012-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486757, encodeId=1d441486e57ce, content=<a href='/topic/show?id=8ca1102515ec' target=_blank style='color:#2F92EE;'>#高甘油三酯血症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102515, encryptionId=8ca1102515ec, topicName=高甘油三酯血症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91bf8208819, createdName=bioon4, createdTime=Thu Oct 04 14:01:00 CST 2012, time=2012-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1571918, encodeId=212915e1918bf, content=<a href='/topic/show?id=413922e74cd' target=_blank style='color:#2F92EE;'>#临床实践指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22774, encryptionId=413922e74cd, topicName=临床实践指南)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=276d15780972, createdName=lily1621, createdTime=Thu Oct 04 14:01:00 CST 2012, time=2012-10-04, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=1654705, encodeId=7f221654e05ff, content=<a href='/topic/show?id=edc610251468' target=_blank style='color:#2F92EE;'>#高甘油三酯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102514, encryptionId=edc610251468, topicName=高甘油三酯)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5a424532179, createdName=flyingeagle85, createdTime=Sat Nov 10 14:01:00 CST 2012, time=2012-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2030968, encodeId=fbf32030968b3, content=<a href='/topic/show?id=5df2460e269' target=_blank style='color:#2F92EE;'>#实践指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46072, encryptionId=5df2460e269, topicName=实践指南)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=796422, createdName=lvliquan, createdTime=Sun Mar 24 04:01:00 CST 2013, time=2013-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5153, encodeId=b282515310, content=有现实意义, beContent=null, objectType=article, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed5e73319, createdName=luglei, createdTime=Tue Dec 04 01:28:00 CST 2012, time=2012-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5154, encodeId=eeb35154a3, content=有现实意义, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed5e73319, createdName=luglei, createdTime=Tue Dec 04 01:28:00 CST 2012, time=2012-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1323587, encodeId=84c2132358ed9, content=<a href='/topic/show?id=42b922e7350' target=_blank style='color:#2F92EE;'>#临床实践#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22773, encryptionId=42b922e7350, topicName=临床实践)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=35fc2500023, createdName=yanjie6253_56072842, createdTime=Thu Oct 04 14:01:00 CST 2012, time=2012-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486757, encodeId=1d441486e57ce, content=<a href='/topic/show?id=8ca1102515ec' target=_blank style='color:#2F92EE;'>#高甘油三酯血症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102515, encryptionId=8ca1102515ec, topicName=高甘油三酯血症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91bf8208819, createdName=bioon4, createdTime=Thu Oct 04 14:01:00 CST 2012, time=2012-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1571918, encodeId=212915e1918bf, content=<a href='/topic/show?id=413922e74cd' target=_blank style='color:#2F92EE;'>#临床实践指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22774, encryptionId=413922e74cd, topicName=临床实践指南)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=276d15780972, createdName=lily1621, createdTime=Thu Oct 04 14:01:00 CST 2012, time=2012-10-04, status=1, ipAttribution=)]

相关资讯

FDA批准Vascepa治疗高甘油三酯血症

    2012年7月26日,美国食品与药物管理局(FDA)批准专利合成药乙基二十五碳五烯酸(EPA)(Vascepa,既往称为AMR101)用于治疗高甘油三酯血症,Vascepa成为市场上第二个ω-3多不饱和脂肪酸(PUFA)处方药。   该药制造商Amarin的报告指出,Vascepa是一种纯化的海洋油制剂,含有“不低于96%”的EPA,而另一种活性ω-3 PUFA(二